FDA Adverse Event Injury Summary report: N

SPRINT QUATTRO SECURE MRI SURESCAN

MDR report key: 2951952 · Received February 9, 2013

Report

Report Number
2649622-2013-00315
Event Type
Injury
Date Received
February 9, 2013
Date of Event
November 8, 2012
Report Date
August 9, 2021
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PRODUCT EVENT SUMMARY: THE LEAD WAS NOT RETURNED FOR ANALYSIS. WE DID RECEIVE PERFORMANCE DATA COLLECTED FROM THE DEVICE AND HAVE ANALYZED THE DATA. THERE WAS A PATIENT ALERT FOR OUT OF TOLERANCE SUB-THRESHOLD LEAD IMPEDANCE ON (B)(6) 2012. THE DAILY PACE LEAD TREND DATA SHOWED AN INCREASE FOR SUPERIOR VENA CAVA (SVC) IMPEDANCE FROM 62 TO 104 OHMS BETWEEN (B)(6) 2012.

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. (B)(4).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE SUPERIOR VENA CAVA (SVC) COIL IMPEDANCE TRIGGERED AN ALERT FOR BEING OUT OF RANGE. THE IMPEDANCE TREND SHOWED A SUDDEN INCREASE TO A HIGH MEASUREMENT. THE RIGHT VENTRICULAR (RV) LEAD COIL WAS SLIGHTLY HIGHER THAN IT HAD BEEN. THE SVC COIL WAS PROGRAMMED TO OFF AND THE LEAD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Description of Event or Problem · 1

IT WAS FURTHER REPORTED THAT THE LEAD EXHIBITED SLOWLY INCREASING PACING IMPEDANCES TO HIGH LEVELS. THE LEAD REMAINS IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
57398 SPRINT QUATTRO SECURE MRI SURESCAN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) LWS MPRI 694758

Patients

Seq Age Sex Outcome Treatment
1 00064 YR Required Intervention (B)(4) IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (IC| (B)(4) IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (IC